摘要
小细胞肺癌( S C L C) 常规治疗的效果不佳,但提高化疗药物的剂量强度可以改善预后。高剂量化疗( H D C) 联合自体造血干细胞移植( A S C T) 治疗 S C L C 的结果表明,局限期患者在诱导化疗达到完全缓解或接近完全缓解后接受移植,可以提高无病生存率,延长生存期,但对广泛期及复发耐药者的长期生存并无改善。造血干细胞移植在综合治疗中的地位,怎样合理安排各种治疗手段以及造血干细胞产品的纯化等问题有待进一步的深化和研究。
出处
《国外医学(肿瘤学分册)》
北大核心
1999年第5期296-298,共3页
Foreign Medical Sciences (Cancer Section)
参考文献1
-
1S. Fetscher,W. Brugger,R. Engelhardt,L. Kanz,J. Hasse,H. Frommhold,M. Wenger,W. Lange,R. Mertelsmann. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer[J] 1997,Annals of Oncology(1):49~56
同被引文献24
-
1白连启,李世业,陈肖嘉,刘树库,龚昌帆,彭延生.474例小细胞肺癌的治疗分析[J].中华胸心血管外科杂志,1996,12(4):211-213. 被引量:15
-
2[3]徐振晔,杨宇飞.肺癌:总论[M].北京:人民卫生出版社,2002.3-4.
-
3[6]HAINSWORTH J D, GRECO F A. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer[J]. Semin Oncol, 1999, 26(1 Suppl2): 60-66.
-
4[7]MARTIN R, JOACHIM VON P, HANS NICOLAS, et al.Randomized phase Ⅲ treal of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vinccristine in patients withsmall-cell lung cancer[J]. JNCI, 2003, 95(15): 1 118-1 127.
-
5[8]HUISMANC, POSTMUSPE, GIACCONEG, et al. Seconded-line chemotherapy and evaluation in small cell lung cancer[J].Cancer Treat Rev, 1999, 25(4): 199-206.
-
6[9]ARGIRIS A, MURREN J R. Advances in chemotherapy for small cell lung cancer: Single-agent activity of newer agents[J].Cancer J, 2001, 7(3): 228-235.
-
7[10]KRREN K. New chemotherapy agents for small cell lung cancer[J]. Chest, 2000, 117: 156-162.
-
8[12]THATCHER N, GIRLING D J, HOPWOOD P, et al. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council multicenter randomized trial[J]. Clin Oncol, 2000, 18(2): 395-404.
-
9[13]LEYVRAZS, PEREYL, ROSTI G, etal. Multiple course of high-dose ifosamide, carboplatin, and etopcside with perpheral-blood progenitor cells and filgrastim for small-cell lung cancer:a feasibility study by the European Group for Blood and Marrow Transplantation[J]. Clin Oncol, 1999, 17(11): 3 531-3 539.
-
10[15]AUPERINA, ARRIAGADAR, PIGNONJP, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group[J]. N Engl J Med, 1999, 341(7): 476-484.
-
1吴世凯,石远凯,王奇璐.高剂量化疗合并自体骨髓移植治疗乳腺癌[J].国外医学(肿瘤学分册),1995,22(3):154-157. 被引量:1
-
2滕清良,张春梅,孙兆刚,李秀兰,黎爱华,张华治.大剂量化疗联合自体造血干细胞移植治疗恶性血液病临床研究[J].山东医药,2005,45(16):22-23. 被引量:1
-
3段丽丽,戚威,孙晓辉.大剂量化疗联合自体造血干细胞移植治疗恶性黑色素瘤[J].国外医学(肿瘤学分册),1999,26(5):311-312. 被引量:1
-
4滕清良,张春梅,孙兆刚,李秀兰,黎爱华,张华治.大剂量化疗联合自体造血干细胞移植治疗恶性血液病(附16例报告)[J].山东医药,2003,43(28):29-30.
-
5张贵鹏,王占聚,崔为发,刘永,唐瑛,陈蕾,马红星.弥漫性大B细胞淋巴瘤IL-6和VEGF表达水平与化疗耐药的相关性[J].现代医药卫生,2012,28(4):488-489. 被引量:2
-
6江亚军(综述),顾健(审校).Livin与恶性肿瘤的研究进展[J].医学综述,2008,14(15):2267-2270. 被引量:1
-
7张俊廷,王亮,吴震,贾桂军,张力伟.颅底脊索瘤患者生存因素分析[J].中华医学杂志,2007,87(23):1607-1610. 被引量:7
-
8冯洁枝,郑赛风,张慧珍,冯桂荣,杨天珍.乳腺癌前哨淋巴结活检及清扫术患者的护理[J].南方护理学报,2004,11(10):23-24. 被引量:1
-
9沈镇宙,张亚伟.高剂量化疗和外周血干细胞支持在乳腺癌中的应用价值[J].实用肿瘤杂志,1999,14(3):135-137.
-
10廖美琳.高剂量化疗外周血干细胞支持治疗肺癌的进展[J].实用肿瘤杂志,1999,14(3):137-139. 被引量:2